Lab results
Full transparency, per batch.
Every production batch is tested by an independent, accredited laboratory using HPLC and mass spectrometry. The corresponding Certificate of Analysis can be downloaded below.
Featured report
Retatrutide 30 mg Vial - 99.735% purity.
Independently tested by Janoshik Analytical (task #105536). Batch SN-TP-R30-B2601, analysis performed on 5 February 2026.
- Purity
- 99.735%
- Measured content
- 30.16 mg
- Method
- HPLC / MS
- Laboratory
- Janoshik Analytical
Verification code: C23Y5;MMK32F
All COAs
9 results available
BPC-157 TB-500 10 + 10 mg Vial
Janoshik Analytical · HPLC / MS · 2026-06-12
COA coming soon
BPC-157 TB-500 Research Reference
Janoshik Analytical · HPLC / MS · 2026-06-04
COA coming soon
GHK-CU 50 mg Vial
Simec AG · HPLC · 2026-05-28
COA coming soon
Selank Research Reference
Janoshik Analytical · HPLC / MS · 2026-05-20
COA coming soon
Tesamorelin Research Reference
Janoshik Analytical · HPLC / MS · 2026-05-09
COA coming soon
IGF1-LR3 Research Reference
Simec AG · HPLC · 2026-04-29
COA coming soon
CJC-1295 Research Reference
Janoshik Analytical · HPLC / MS · 2026-04-18
COA coming soon
MOTS-c
Simec AG · HPLC · 2026-04-05
COA coming soon
Method
HPLC
High Performance Liquid Chromatography measures purity and the presence of impurities.
Method
Mass spectrometry
Confirms the exact molecular mass and identity of the peptide.
Method
Bacterial culture
Optional microbiological check for contamination of the lyophilisate.